In the past week, QDEL stock has gone up by 2.38%, with a monthly decline of -5.10% and a quarterly plunge of -8.95%. The volatility ratio for the week is 4.82%, and the volatility levels for the last 30 days are 4.55% for QuidelOrtho Corporation The simple moving average for the past 20 days is 3.61% for QDEL’s stock, with a -1.00% simple moving average for the past 200 days.
Is It Worth Investing in QuidelOrtho Corporation (NASDAQ: QDEL) Right Now?
QDEL has 36-month beta value of 0.10. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 2 as “overweight,” 3 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for QDEL is 66.27M, and currently, short sellers hold a 5.90% ratio of that float. The average trading volume of QDEL on December 11, 2024 was 825.76K shares.
QDEL) stock’s latest price update
The stock of QuidelOrtho Corporation (NASDAQ: QDEL) has increased by 5.95 when compared to last closing price of 38.50.Despite this, the company has seen a gain of 2.38% in its stock price over the last five trading days. businesswire.com reported 2024-12-10 that SAN DIEGO–(BUSINESS WIRE)–QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced the appointments of John R. Chiminski and R. Scott Huennekens to its board of directors (the “Board”), effective December 6, 2024. These appointments align with QuidelOrtho’s commitment to maintaining a strong, independent Board with the ri.
Analysts’ Opinion of QDEL
Jefferies, on the other hand, stated in their research note that they expect to see QDEL reach a price target of $43. The rating they have provided for QDEL stocks is “Hold” according to the report published on December 10th, 2024.
UBS gave a rating of “Neutral” to QDEL, setting the target price at $50 in the report published on September 19th of the current year.
QDEL Trading at 1.64% from the 50-Day Moving Average
After a stumble in the market that brought QDEL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -46.23% of loss for the given period.
Volatility was left at 4.55%, however, over the last 30 days, the volatility rate increased by 4.82%, as shares sank -0.22% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -7.15% lower at present.
During the last 5 trading sessions, QDEL rose by +3.04%, which changed the moving average for the period of 200-days by -12.29% in comparison to the 20-day moving average, which settled at $39.38. In addition, QuidelOrtho Corporation saw -44.65% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at QDEL starting from Robert Bujarski, who proposed sale 20,000 shares at the price of $40.40 back on Dec 09 ’24. After this action, Robert Bujarski now owns shares of QuidelOrtho Corporation, valued at $808,000 using the latest closing price.
Carlyle Group Inc., the 10% Owner of QuidelOrtho Corporation, sale 8,260,183 shares at $35.31 during a trade that took place back on Nov 21 ’24, which means that Carlyle Group Inc. is holding 0 shares at $291,700,102 based on the most recent closing price.
Stock Fundamentals for QDEL
Current profitability levels for the company are sitting at:
- 0.01 for the present operating margin
- 0.42 for the gross margin
The net margin for QuidelOrtho Corporation stands at -0.66. The total capital return value is set at 0.01. Equity return is now at value -45.79, with -24.34 for asset returns.
Based on QuidelOrtho Corporation (QDEL), the company’s capital structure generated 0.44 points at debt to capital in total, while cash flow to debt ratio is standing at 0.04. The debt to equity ratio resting at 0.8. The interest coverage ratio of the stock is 0.17.
Currently, EBITDA for the company is 545.6 million with net debt to EBITDA at -1.86. When we switch over and look at the enterprise to sales, we see a ratio of 1.89. The receivables turnover for the company is 8.42for trailing twelve months and the total asset turnover is 0.41. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.38.
Conclusion
To put it simply, QuidelOrtho Corporation (QDEL) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
